Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Mitral regurgitation after anthracycline treatment for childhood malignancy
Autore:
Allen, J; Thomson, JDR; Lewis, IJ; Gibbs, JL;
Indirizzi:
Gen Infirm, Dept Paediat Cardiol, Yorkshire Heart Ctr, Leeds LS1 3EX, W Yorkshire, England Gen Infirm Leeds W Yorkshire England LS1 3EX S1 3EX, W Yorkshire, England Leeds Gen Infirm, Dept Paediat Oncol, Leeds, W Yorkshire, England Leeds Gen Infirm Leeds W Yorkshire England , Leeds, W Yorkshire, England
Titolo Testata:
HEART
fascicolo: 4, volume: 85, anno: 2001,
pagine: 430 - 432
SICI:
1355-6037(200104)85:4<430:MRAATF>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
QT INTERVAL PROLONGATION; RISK-FACTORS; CARDIOTOXICITY; ADRIAMYCIN; CHILDREN; CANCER;
Keywords:
anthracyclines; mitral regurgitation; cardiomyopathy;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
15
Recensione:
Indirizzi per estratti:
Indirizzo: Gibbs, JL Gen Infirm, Dept Paediat Cardiol, Yorkshire Heart Ctr, E Floor,Jubilee Wing,Great George St, Leeds LS1 3EX, W Yorkshire, England Gen InfirmE Floor,Jubilee Wing,Great George St Leeds W Yorkshire England LS1 3EX
Citazione:
J. Allen et al., "Mitral regurgitation after anthracycline treatment for childhood malignancy", HEART, 85(4), 2001, pp. 430-432

Abstract

Objective-To investigate the new onset of mitral regurgitation in patientswith otherwise normal echocardiograms after anthracycline treatment and toassess its relation to other selected indicators of myocardial damage. Design-Prospective echocardiographic and electrocardiographic study. Setting-Tertiary paediatric cardiac referral centre. Patients-305 patients, aged 2-33 years (median 14 years), treated with cumulative anthracycline doses of between 150-450 mg/m(2) (median 180 mg/m(2))for childhood malignancy. Main outcome measures--Colour flow Doppler detection of mitral regurgitation and its relation to changes in echocardiographic indices of left ventricular function (systolic and diastolic dimensions, fractional shortening) and to changes in the 12 lead EGG; and the prevalence of mitral regurgitationin the anthracycline treated patients in comparison with previously studied normal volunteers of similar age. Results-34 patients (11.6%) developed ultrasound detectable mitral regurgitation, which was not apparent clinically, during or after anthracycline treatment, compared with only 1.8% of a normal population of similar age (p <0.0001). Nine of the 34 also developed non-specific T wave abnormalities. All 34 patients had normal systolic function at the time of initial detection of mitral regurgitation, but four later developed impaired left ventricular function (5, 11, 20, and 27 months after the first detection of mitral regurgitation). Conclusions-Mitral regurgitation occurs much more often in patients treated with anthracyclines than in the normal population. Echocardiographic detection of new mitral regurgitation with or without ECG abnormalities may be an early predictor of anthracycline cardiomyopathy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 20:12:51